β-Amyloid (4-10) is an epitope for the polyclonal anti-Aβ(1-42) antibody, reduces amyloid deposition in a transgenic Alzheimer disease mouse model.
β-Amyloid 4-10 is a synthetic peptide fragment corresponding to residues 4 through 10 of the human amyloid beta (Aβ) protein sequence. As a truncated segment of the amyloid beta peptide, it is widely utilized in neurological and biochemical research, particularly in studies investigating the molecular underpinnings of amyloid aggregation processes. Its defined sequence and physicochemical properties make it a valuable tool for dissecting the structure-function relationships of amyloidogenic peptides, as well as for exploring the early events in amyloid fibril formation. Researchers leverage this peptide to model specific regions of the amyloid beta protein, allowing for precise interrogation of sequence-dependent effects on aggregation, toxicity, and protein-protein interactions.
Aggregation Studies: In the context of amyloid research, the 4-10 fragment serves as a critical probe for analyzing the intrinsic aggregation propensity of specific Aβ regions. By isolating this segment, scientists can assess its ability to self-associate or co-aggregate with other amyloidogenic peptides under controlled conditions. Such studies are essential for elucidating the minimal sequence requirements for β-sheet formation and for mapping the nucleation sites that initiate amyloid fibril assembly. Insights gained from these experiments contribute to a deeper understanding of the molecular mechanisms driving amyloidogenesis.
Structure-Activity Relationship Analysis: The defined sequence of this peptide enables systematic investigation of structure-activity relationships within the amyloid beta protein. Researchers frequently employ it in biophysical and spectroscopic assays, such as circular dichroism or NMR, to characterize conformational preferences and secondary structure elements. These analyses provide valuable information on how specific amino acid residues within the 4-10 region influence peptide folding, intermolecular interactions, and the formation of oligomeric or fibrillar assemblies.
Peptide-Protein Interaction Studies: The 4-10 segment is often used to probe interactions between amyloid beta fragments and a variety of binding partners, including antibodies, chaperones, and small molecule modulators. By focusing on this discrete region, it becomes possible to map epitope recognition sites, quantify binding affinities, and evaluate the impact of sequence truncation on protein-protein or protein-ligand interactions. Such studies are instrumental in identifying molecular determinants of recognition and in guiding the design of peptide-based probes or inhibitors for research applications.
Analytical Method Development: The peptide is frequently utilized as a reference standard or calibration tool in the development and validation of analytical methods for amyloid detection and quantification. Its well-defined sequence and stability make it suitable for use in mass spectrometry, HPLC, and immunoassay platforms, where it can serve as a benchmark for sensitivity, specificity, and reproducibility. Employing this fragment as a control enhances the reliability of analytical workflows in both basic and applied amyloid research.
Model System for Peptide Modification: The 4-10 fragment provides a versatile scaffold for chemical modification and the study of sequence alterations, post-translational modifications, or labeling strategies. By introducing targeted substitutions or functional groups, researchers can systematically evaluate the effects of chemical modifications on peptide behavior, aggregation kinetics, and biophysical properties. This approach supports the rational design of peptide analogs and the optimization of biochemical assays involving amyloidogenic sequences.
Collectively, these application areas underscore the value of the 4-10 amyloid beta fragment as a specialized research tool in peptide biochemistry and neurodegenerative disease investigations. Its utility spans fundamental studies of aggregation mechanisms to the development of analytical techniques and model systems for peptide engineering, making it an indispensable component in the toolkit of amyloid researchers.
1. Cationic cell-penetrating peptides are potent furin inhibitors
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More